NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Occupation and Asthma in an Urban Low Income Population

Completed
Conditions
First Posted Date
2001-04-12
Last Posted Date
2015-12-18
Lead Sponsor
NYU Langone Health
Target Recruit Count
800
Registration Number
NCT00014820

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

First Posted Date
2000-12-18
Last Posted Date
2016-03-11
Lead Sponsor
NYU Langone Health
Target Recruit Count
150
Registration Number
NCT00007358
Locations
🇺🇸

New York University Medical Center, New York, New York, United States

🇺🇸

St. Barnabas Medical Center, Livingston, New Jersey, United States

🇺🇸

Hospital for Joint Diseases, New York, New York, United States

and more 1 locations

Tuberculosis in a Multiethnic Inner City Population

First Posted Date
2000-05-26
Last Posted Date
2015-12-29
Lead Sponsor
NYU Langone Health
Registration Number
NCT00005379

Endogenous Estrogen and Coronary Heart Disease in Women

First Posted Date
2000-05-26
Last Posted Date
2015-12-31
Lead Sponsor
NYU Langone Health
Registration Number
NCT00005446

Intermittent ST Depression and Prognosis After Myocardial Infarction

First Posted Date
2000-05-26
Last Posted Date
2016-01-28
Lead Sponsor
NYU Langone Health
Registration Number
NCT00005217

Occluded Artery Trial (OAT)

First Posted Date
2000-02-10
Last Posted Date
2014-04-21
Lead Sponsor
NYU Langone Health
Target Recruit Count
2201
Registration Number
NCT00004562
Locations
🇺🇸

New York University School of Medicine, New York, New York, United States

Safety of Estrogens in Lupus: Birth Control Pills

Phase 3
Completed
Conditions
First Posted Date
1999-11-04
Last Posted Date
2013-05-03
Lead Sponsor
NYU Langone Health
Target Recruit Count
350
Registration Number
NCT00000420
Locations
🇺🇸

Louisiana School of Medicine, Dept. of Medicine/Immunology, Shreveport, Louisiana, United States

🇺🇸

UCLA Medical Center, Dept. of Rheumatology, Los Angeles, California, United States

🇺🇸

University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States

and more 12 locations

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

Phase 2
Completed
Conditions
Interventions
First Posted Date
1999-11-04
Last Posted Date
2016-03-04
Lead Sponsor
NYU Langone Health
Target Recruit Count
154
Registration Number
NCT00000421
Locations
🇺🇸

Office of Betty Diamond, M.D., Bronx, New York, United States

🇺🇸

North Shore-Long Island Jewish Health System, New Hyde Park, New York, United States

🇺🇸

Lenox Hill Hospital, New York, New York, United States

Safety of Estrogens in Lupus: Hormone Replacement Therapy

Phase 3
Terminated
Conditions
First Posted Date
1999-11-04
Last Posted Date
2013-05-03
Lead Sponsor
NYU Langone Health
Target Recruit Count
350
Registration Number
NCT00000419
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

🇺🇸

University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States

🇺🇸

Univ. of Pittsburgh, Dept. of Rheumatology, Pittsburgh, Pennsylvania, United States

and more 13 locations
© Copyright 2024. All Rights Reserved by MedPath